BELRAPZO

Eagle Pharmaceuticals, Inc🇺🇸 United States

FDA Page

Effective Date: Jan 19, 2024
Approval ID: 9759a4ae-82ca-40cf-9c02-e1cadb21cbdc
Products: 1 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BELRAPZO safely and effectively. See full prescribing information for BELRAPZO. BELRAPZO (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 2008

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.